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Flap endonuclease 1 (FEN1) is a member of the nuclease
family and is structurally conserved from bacteriophages to
humans. This protein is involved in multiple DNA-processing
pathways, including Okazaki fragment maturation, stalled
replication-fork rescue, telomere maintenance, long-patch
base-excision repair and apoptotic DNA fragmentation.
FEN1 has three functional motifs that are responsible for its
nuclease, PCNA-interaction and nuclear localization activities,
respectively. It has been shown that the C-terminal nuclear
localization sequence (NLS) facilitates nuclear localization of
the enzyme during the S phase of the cell cycle and in response
to DNA damage. To determine the structural basis of the
recognition of FEN1 by the nuclear import receptor importin
, the crystal structure of the complex of importin  with
a peptide corresponding to the FEN1 NLS was solved.
Structural studies confirmed the binding of the FEN1 NLS as a
classical bipartite NLS; however, in contrast to the previously
proposed 354KRKX8KKK
367 sequence, it is the 354KRX10KK-
AK369 sequence that binds to importin . This result explains
the incomplete inhibition of localization that was observed on
mutating residues 365KKK367. Acidic and polar residues in the
X10 linker region close to the basic clusters play an important
role in binding to importin . These results suggest that the
basic residues in the N-terminal basic cluster of bipartite NLSs
may play roles that are more critical than those of the many
basic residues in the C-terminal basic cluster.
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1. Introduction
Flap endonuclease 1 (FEN1) is a member of the 50 nuclease
family and is structurally conserved from bacteriophages to
humans (Mase et al., 2011). FEN1 is a 40 kDa protein and
contains two metal-ion-binding sites (Hwang et al., 1998;
Hosfield et al., 1998). This protein is involved in multiple DNA-
processing pathways, including Okazaki fragment maturation,
stalled replication-fork rescue, telomere maintenance, long-
patch base-excision repair and apoptotic DNA fragmentation
(Zheng et al., 2011).
FEN1 has three functional motifs which are responsible for
its nuclease activity, interaction with PCNA (proliferating cell
nuclear antigen) and nuclear localization, respectively. Several
crystal structures of FEN1 have been elucidated from archaea
(Mase et al., 2011) and humans (Sakurai et al., 2005; Tsuta-
kawa et al., 2011). FEN1–DNA structural complexes revealed
that motifs that are conserved in the nuclease family are
responsible for binding and cleaving the DNA (Tsutakawa et
al., 2011). The FEN1 construct that was used in the structure
determination of the human FEN1–DNA complex was trun-
cated at residue 336 owing to the high flexibility of the
C-terminal region.
Nuclear localization sequences (NLSs) were identified in
the C-terminal region of FEN1 following the PCNA-binding
motif; in the case of human FEN1 the NLS corresponds to
residues 354–370 (Qiu et al., 2001). It has been shown that this
signal facilitates nuclear localization of the enzyme during the
S phase of the cell cycle and in response to DNA damage.
Truncation of the NLS motif prevents translocation of the
protein from the cytoplasm to the nucleus, but does not affect
its nuclease activity. Site-directed mutagenesis experiments
demonstrated that the mutation of 354KRK356 to alanine
residues completely blocked the localization of enzyme into
the nucleus, while analogous mutation of 365KKK367 only led
to a partial block of translocation (Qiu et al., 2001). This NLS
has been proposed to involve the classical importin  (Imp)/
importin  (Imp) mediated nuclear import pathway (Koike
et al., 1999, 2001; Bertinato et al., 2001).
The classical NLSs (cNLSs) contain one or two clusters of
positively charged amino acids and are therefore usually
divided into monopartite cNLSs, which contain a single cluster
of basic residues, and bipartite cNLSs, which contain two
clusters of basic residues separated by 10–12 variant residues
(termed linker residues; Fontes, Teh, Jans et al., 2003). Struc-
tural studies have shown that both classes are recognized by
the nuclear import receptor Imp (Conti & Kuriyan, 2000;
Fontes et al., 2000). This protein has two NLS-binding regions
formed by conserved residues in its armadillo (ARM) repeat
domain, termed the major and minor NLS-binding sites. The
N-terminal (positions P10–P20) and C-terminal (positions P1–
P6) clusters of a bipartite NLS interact with the minor and
major NLS-binding sites, which correspond to ARM repeats
4–8 and 1–4, respectively, while a monopartite NLS primarily
interacts with the major binding site (Conti & Kuriyan, 2000;
Fontes et al., 2000; Rexach & Blobel, 1995). Taking the
mutagenesis studies into account in combination with nuclear
localization experiments on FEN1 led to the hypothesis that
the enzyme has a classical bipartite NLS (Qiu et al., 2001).
Nuclear localization is a fundamental control mechanism
that allows the cell to regulate DNA replication, DNA repair
and many other biological nuclear functions. Although many
NLSs have been identified, understanding of the specificity of
NLS recognition and regulation remains limited (Marfori et al.,
2011). The abolition of nuclear localization of FEN1 resulted
in in vivo defects in DNA synthesis and in the repair of DNA
damage (Qiu et al., 2001), highlighting its key role in regu-
lating physiological nuclear functions.
With the aim of testing the prediction of a bipartite NLS in
FEN1 and gaining insight into both the function of FEN1 and
the nuclear import process, we solved the crystal structure of
the peptide corresponding to the FEN1 NLS bound to Imp.
Our results confirmed that the proposed sequence binds to
both the major and the minor sites and is consequently a
bipartite NLS. Previous studies proposed that the bipartite
NLS comprised the sequence KRKX8KKK, but we found that
the sequence instead corresponded to KRX10KKAK. This
result may explain why only partial blockage of localization
resulted from the mutation of residues 365KKK367; the major-
site-binding residues instead correspond to 366KKAK369. We
also show that the FEN1 NLS peptide has an affinity for Imp
that is comparable to those of other bipartite NLSs as
measured by a solid-phase binding assay. Our study highlights
the importance of interactions with Imp involving the NLS
linker region and the key role of the minor NLS-binding site.
2. Materials and methods
2.1. Synthesis of NLS peptides
The peptide corresponding to human FEN1 NLS (351SSA-
KRKEPEPKGSTKKKAKT370; FEN1NLS) was synthesized
by Proteimax (Brazil) with a purity of higher than 99%. The
peptides contained additional residues at the N- and C-termini
compared with the minimal identified NLS (Knudsen et al.,
2009) in order to avoid artifactual binding at the termini
(Fontes et al., 2000; Marfori et al., 2012).
2.2. Protein expression and purification
Hexa-His-tagged truncated Mus musculus importin 2,
comprising amino acids 70–529 (mImpIBB), was expressed
and purified by nickel-affinity chromatography as described
previously (Teh et al., 1999). The protein was eluted using
an imidazole gradient, followed by dialysis. The Imp sample
was stored in a buffer composed of 20 mM Tris–HCl pH 8.0,
100 mM sodium chloride, 10 mM DTT at 253 K. The purity
was estimated to be 98% by SDS–PAGE.
2.3. Quantitative binding assay
GST-FEN1NLS fusion protein was expressed in Escherichia
coli BL21 (DE3) for 6 h at 310 K followed by 18 h at 293 K in
auto-induction medium (Studier, 2005). The bacterial pellet
was resuspended in GST-A buffer (50 mM Tris–HCl, 1 mM
DTT, 125 mM NaCl at pH 7.8) and underwent three freeze-
thaw cycles before purification. 1 mg ml1 lysozyme, 1 mg
DNAase and 1 mM PMSF (Sigma) were added to the cell
crude extract and mixed thoroughly. After centrifugation, the
soluble fraction was loaded onto a GSTrap column (5 ml; GE
Healthcare) and washed with 100 ml GST-A buffer. After
washing, the GST-FEN1NLS protein was eluted with GST-B
buffer (50 mM Tris–HCl, 125 mM NaCl, 1 mM DTT, 10 mM
reduced glutathione at pH 7.8). The eluted fractions were
pooled and concentrated prior to gel-filtration purification
using a Superdex 200 (20/60) gel-filtration column (GE
Healthcare). Pure GST-FEN1NLS protein was concentrated
using an Amicon Ultra centrifugal filter device (10 kDa
cutoff).
The solid-phase binding assay was performed essentially as
described previously by Takeda et al. (2011). The assay was
carried out in an Immuno MaxiSorp 96-well plate (Thermo
Fisher Scientific). The wells were coated with 50 nM GST-
FEN1NLS or GST. Binding reactions were carried out for 2 h
at 277 K with 100 ml S-tagged mImpIBB (0–20 mM in a 2
serial dilution) in binding buffer per well. After binding and a
few steps of washing, the plates were incubated in S-protein-
horseradish peroxidase conjugate (Novagen). Horseradish
peroxidase substrate (100 mg ml1 3,30,5,50-tetramethylbenzi-
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dine; Sigma) was added for 20 min at room temperature and
the reaction was stopped by adding an equal volume of 0.5M
H2SO4. The signal was determined at 450 nm with a Molecular
Devices plate reader (Spectra Max 250). Average absorbance
values at OD450 were determined for GSTand GST-FEN1NLS
at each S-tagged mImpIBB concentration. Background
absorbance values (without mImpIBB) were subtracted.
The average absorbance values were used to generate binding
curves by nonlinear regression using the GraphPad Prism
software. The apparent dissociation constants (Kd) for the
binding of mImpIBB to GST and GST-FEN1 were also
calculated using the GraphPad Prism software. The curves
were plotted against the serial concentration of mImpIBB
and were fitted using the equation
Y ¼ BmaxXðKd þ XÞ
; ð1Þ
where X is the concentration of the protein, Bmax is the
maximum specific binding and Kd is the apparent dissociation
constant representing the protein concentration yielding half-
maximal binding.
2.4. Crystallization and crystal structure determination
mImpIBB was concentrated to 20 mg ml1 using an
Amicon 30 kDa cutoff filter unit (Millipore) and was stored at
253 K. Crystallization conditions were screened by system-
atically altering various parameters, using as a starting point
the crystallization conditions that had been successful for
other peptide complexes (Fontes, Teh, Jans et al., 2003; Fontes
et al., 2000). Crystals were obtained by cocrystallization by
combining 1 ml protein solution, 0.5 ml peptide solution
(peptide:protein molar ratio of 8:1 for the FEN1NLS peptide)
and 1 ml reservoir solution on a cover slip and suspending the
mixture over 0.5 ml reservoir solution. Single crystals were
obtained using a reservoir solution consisting of 0.60–0.65 M
sodium citrate pH 5.8, 10 mM DTT after 15–20 d.
X-ray diffraction data were collected at a wavelength of
1.45 A˚ on the MX-2 beamline at the Laborato´rio Nacional
de Luz Sı´ncrotron synchrotron-radiation source (Campinas,
Brazil) with a MARMosaic 225 imaging-plate detector (MAR
Research). The crystals were mounted in nylon loops, tran-
siently soaked in reservoir solution supplemented with 25%
glycerol and flash-cooled at 100 K in a nitrogen stream
(Oxford Nitrogen Cryojet XL, Oxford Cryosystems). Data
were processed using the HKL-2000 package (Otwinowski &
Minor, 1997). The crystals had the symmetry of space group
P212121 and were isomorphous to those of other
mImpIBB–NLS peptide complexes (Table 1). The struc-
ture of the complex with CN-SV40TAg NLS (PDB entry 1q1s;
Fontes, Teh, Toth et al., 2003) with the NLS peptide omitted
was employed as a starting model for crystallographic refine-
ment. After rigid-body refinement using the program
REFMAC5 (Murshudov et al., 2011), inspection of the elec-
tron-density map confirmed the presence of the peptide in
both the major and minor NLS-binding sites of the protein.
Rounds of crystallographic refinement with REFMAC5
(positional and restrained isotropic individual B factors with
an overall anisotropic temperature factor and bulk-solvent
correction) and manual modelling using the program Coot
(Emsley & Cowtan, 2004) were used to improve the model,
considering free R factors. The final model of the
mImpIBB–FEN1NLS complex consisted of 425 residues of
Imp (72–496), one peptide ligand (19 residues could be
modelled) and 157 water molecules (Table 1). Structure
quality was checked using the program PROCHECK
(Laskowski et al., 1996) and the contacts were analyzed using
the program LIGPLOT (Wallace et al., 1995).
3. Results
3.1. Structure of importin a complexed with a peptide
corresponding to FEN1 NLS
A peptide corresponding to human FEN1 NLS (FEN1NLS)
was cocrystallized with N-terminally truncated mouse Imp
lacking residues 1–69 (mImpIBB); the truncated residues
are responsible for its autoinhibition (Kobe, 1999). Mouse
Imp is a suitable model for the human protein as their highly
interacting residues with NLS peptides are strictly conserved
(including the Trp-Asn array and negatively charged residues
of the major and minor binding sites and Tyr277 and Arg315 of
the linker region; Fontes, Teh, Jans et al., 2003; Marfori et al.,
2011).
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Table 1
X-ray data-collection and refinement statistics for mImpIBB–
FEN1NLS.
Values in parentheses are for the highest resolution shell.
Diffraction data statistics
Unit-cell parameters (A˚) a = 78.87, b = 89.56, c = 100.34
Space group P212121
Resolution (A˚) 40.0–2.38 (2.44–2.38)
Unique reflections 28970
Multiplicity 3.0 (2.5)
Completeness (%) 98.0 (95.6)
Rmerge† (%) 10.5 (68.5)
Average I/(I) 15.0 (2.0)
Refinement statistics
Resolution (A˚) 40.0–2.38 (2.44–2.38)
No. of reflections 28970
Rcryst‡ (%) 16.78
Rfree§ (%) 21.50
No. of non-H atoms
Protein 3237
Peptide 146
Solvent 157
Mean B factor (A˚2) 48.65
Coordinate error} (A˚) 0.213
R.m.s.d. from ideal values}
Bond lengths (A˚) 0.023
Bond angles () 1.961
Ramachandran plot††
Residues in most favoured regions (%) 98
Residues in disallowed regions (%) 0.2
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of an
individual measurement of the reflection with Miller indices hkl and hI(hkl)i is the mean
intensity of this reflection. Calculated for I > 3(I) (Otwinowski & Minor, 1997).
‡ Rcryst =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where |Fobs| and |Fcalc| are the observed and
calculated structure-factor amplitudes, respectively. § Rfree is equivalent to
Rcryst but was calculated with reflections (5%) omitted from the refinement
process. } Calculated based on the Luzzati plot with the program SFCHECK
(Laskowski et al., 1996). †† Calculated with the program PROCHECK (Laskowski
et al., 1996).
The cocrystals were grown under similar conditions to and
were isomorphous to other mouse Imp crystals (Fontes, Teh,
Jans et al., 2003; Fontes et al., 2000). Electron-density maps
based on the Imp model clearly showed electron density
corresponding to the peptide following rigid-body refinement
(Fig. 1). The structure was refined at 2.38 A˚ resolution
(Table 1).
Imp is an elongated protein composed of ten ARM motifs
displayed in tandem (Kobe, 1999; Catimel et al., 2001), each
containing three -helices (H1, H2 and H3; Fontes et al., 2000).
The NLS-binding sites are located in a concave groove on the
surface of Imp. The major binding site is mainly formed by
the H3 helices of ARM repeats 2–4, while the minor site is
located at ARM repeats 7–8. The structure of Imp in the
FEN1NLS complex is essentially identical to those of full-
length Imp and of Imp in previously reported complexes
with bipartite NLS-like peptides. The root-mean-square
deviation (r.m.s.d.) of the C atoms of Imp residues 72–496
is 0.39 A˚ between full-length Imp and the Imp–FEN1NLS
complex.
3.2. Binding of FEN1NLS to importin a
The peptide corresponding to the FEN1 NLS, 351SSAKR-
KEPEPKGSTKKKAKT370, binds to both the minor and the
major sites of Imp, with the main chain positioned in an
antiparallel configuration when compared with the direction
of the ARM repeats. Residues 352–370 of the FEN1NLS
peptide (residue 351 had no interpretable electron density)
could be unambiguously identified in the electron-density
maps (Fig. 1a). The buried surface between the protein and
the peptide was 1334.7 A˚2.
The average B factor of the FEN1NLS peptide (50.5 A˚2)
was similar to the average B factor of the entire structure
(49.5 A˚2). The major-site-binding residues (residues 365–369,
positions P1–P5) presented lower average B factors (43.5 A˚2)
compared with the whole peptide, and residues Lys366 and
Ala368 (positions P2 and P4) had the lowest B factors (39.2
and 41.0 A˚2, respectively) and the largest number of inter-
actions between the peptide and the conserved residues of
Imp. The residues bound to the minor site (residues 354–357,
positions P10–P40) had average B factors (51.5 A˚2) that were
slightly higher than those of the peptide; Lys355 (position P20)
had the lowest B factor in this region (46.40 A˚2), reflecting the
strong interaction of this residue with the protein. The linker
sequence connecting the residues bound to the major and the
minor sites (residues 356–365, positions P30–P1) also showed
average B factors that were slightly higher (51.44 A˚2) than the
average B factor of the entire FEN1NLS peptide; residues
Lys356, Gly362, Ser363, Thr364 and Lys365 had the lowest B
factors (lower than 48 A˚2). Because most peptide side chains
interact with the protein, they had average B factors in the
range 40–54 A˚2 (only two residues had B factors higher than
54 A˚2). These relatively similar B-factor values along the
entire peptide are not an unusual feature compared with other
bipartite NLSs (Fontes, Teh, Jans et al., 2003; Fontes et al.,
2000).
Comparison of FEN1NLS with other bipartite NLSs
(nucleoplasmin, RB and N1N2; Fontes, Teh, Jans et al., 2003;
Fontes et al., 2000) showed high structural similarity in both
the major and the minor binding sites. The r.m.s.d.s of C
atoms of NLS residues in positions P1–P5 are 0.36, 0.32 and
0.18 A˚, respectively, and the r.m.s.d.s of the residues in posi-
tions P10–P30 are 0.50, 0.09 and 0.10 A˚, respectively, compared
with nucleoplasmin, RB and N1N2. However, the residues of
the NLS peptides in the linker region presented very different
conformations in the different peptides. Comparison of the C
atoms of the linker residues of FEN1NLS (linker positions
P30–P1) with the nucleoplasmin, RB and N1N2 NLSs resulted
in r.m.s.d.s higher than 2.5 A˚ (2.57, 2.55 and 2.57 A˚, respec-
tively; Fig. 2).
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Figure 1
Crystal structure of the Imp–FEN1NLS complex. (a) Overall structure
of the Imp–FEN1NLS complex. Imp is shown as a ribbon diagram.
FEN1NLS (pink) is shown in stick representation. (b) Electron-density
map (coefficients 3|Fobs| 2|Fcalc|) of the Imp–FEN1NLS complex in the
area corresponding to the peptide (contoured at 1.5 s.d.). All peptide
residues were omitted from the model and simulated annealing was run
with a starting temperature of 1000 K.
Figure 2
Comparison of NLS peptide binding to the minor and major NLS-binding
sites. FEN1 (dark pink), N1N2 (light pink; PDB entry 1pjn; Fontes, Teh,
Jans et al., 2003), nucleoplasmin (yellow; PDB entry 1ejy; Fontes et al.,
2000), RB (green; PDB entry 1pjm) and CN-SV40TAg (light blue; PDB
entry 1q1t; Fontes, Teh, Jans et al., 2003) NLSs were superimposed using
the C atoms of the peptides. Positions binding to the major (P1–P5) and
minor binding sites (P10–P40) are identified along the chains.
Despite the structural differences in the linker regions,
conserved residues of Imp have been observed to interact
with different bipartite NLSs in this region. The strictly
conserved residues Arg238, Tyr277 (both in ARM repeat 5)
and Arg315 (ARM repeat 6) of Imp interact with the main
chains or side chains of the residues of all bipartite peptide
linker regions (FEN1, nucleoplasmin, RB and N1N2 NLSs).
In the case of FEN1NLS these three residues interact with the
protein main chain only via hydrogen bonds or hydrophobic
interactions (Fig. 3). These interactions with the peptide main
chain are likely to be responsible for its high stability,
conferring low B-factor values and high-quality electron
density compared with other bipartite NLSs.
In addition, the majority of FEN1 linker residues make
interactions with Imp (except for residues Glu357 and
Pro358; Fig. 3). Again, this is an unusual feature compared
with other bipartite NLS structures solved to date.
3.3. Affinity of FEN1NLS binding to importin a
A solid-phase binding assay was used to measure the affi-
nity of FEN1NLS for Imp (Fig. 4). The apparent dissociation
constant (Kd) of FEN1NLS for mImpIBB corresponded
to 42  6.5 nM. This value is comparable with an optimal
monopartite NLS peptide binding to mImpIBB (53 
15 nM; Yang et al., 2010) and is very similar to the Kd obtained
for the ‘extended’ monopartite Ku70 and CN-SV40TAg NLS
peptides binding to Imp (29 4 and 24 8 nM, respectively;
Takeda et al., 2011; Fontes, Teh, Toth et al., 2003); these NLSs
make critical contacts distinct from those of bipartite NLSs in
the region N-terminal to the basic cluster (Takeda et al., 2011).
All these affinities were measured using techniques similar to
that used here. The Kd values for the binding of the N1N2 and
RB bipartite NLSs were also similar to those for FEN1NLS
(5.4 and 45 nM for N1N2 and RB, respectively; Efthymiadis et
al., 1997; Hu & Jans, 1999).
4. Discussion
4.1. FEN1NLS is a classical bipartite NLS
The two basic clusters at positions 354–356 and 365–367
(KRKX8KKK) have previously been proposed to be respon-
sible for translocation of FEN1 to cell nuclei (Qiu et al., 2001)
by the classical Imp/Imp-mediated nuclear import pathway
(Koike et al., 1999, 2001; Bertinato et al., 2001). In our crystal
structure of the FEN1NLS–Imp complex the FEN1NLS
peptide binds to Imp with Lys354-Arg355-Lys356 residues at
positions P10-P20-P30 (minor site) and Lys365-Lys366-Lys367
at positions P1-P2-P3 (major site). This further places Lys369
at the P5 position. This is in agreement with the bipartite NLS
consensus sequence KRX10–12KK/RXK (Fontes, Teh, Jans et
al., 2003; Go¨rlich et al., 1994).
The affinity of FEN1NLS in the low-nanomolar range is
comparable with those of other bipartite NLSs and extended
monopartite NLSs. In contrast, shorter monopartite NLSs
comprising only the basic cluster have affinities in the high-
nanomolar range [for example, the extended SV40TAg
(CN-SV40Tag) and Ku70 NLSs have fourfold higher affinities
compared with the shorter SV40TAg and Ku80 NLSs,
respectively (Fontes, Teh, Toth et al., 2003; Takeda et al.,
2011)].
4.2. Comparison of bipartite NLSs and the role of their linker
regions
The structures of three other regular-affinity bipartite NLS–
Imp complexes have been solved to date (nucleoplasmin, RB
and N1N2; Fontes, Teh, Jans et al., 2003). A detailed compar-
ison of these structures with
FEN1NLS–Imp sheds light on
the specificity of NLS binding. All
NLS peptides present very similar
conformations in the minor and
major sites, but adopt very
different conformations in the
linker region (between positions
P30 and P1).
Imp uses a Trp-Asn array to
bind the basic clusters in the
minor and major NLS-binding
sites (Fontes et al., 2000). Analo-
gously, the key feature respon-
sible for binding the linker region
involves the strictly conserved
residues Arg315 (ARM repeat 6)
and Tyr277 (ARM repeat 5) that
interrupt the regularity of the
Trp-Asn array. These residues
bind to the main chain (or the
side chain for RB and N1N2
NLSs) of all NLS peptides and
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Figure 3
Schematic diagram of the interactions between FEN1NLS and Imp. The peptide backbone is drawn in
light blue, with the residues identified by their one-letter codes (residues in blue and pink represent the
minor and major binding sites, respectively). FEN1NLS peptide side chains interacting with the protein are
represented in dark blue or black. Imp side-chain residues interacting with the peptide are indicated by
their names and different colours. Polar contacts are shown as dashed lines and hydrophobic contacts are
indicated by arcs with radiating spokes.
appear to be important for bipartite NLS binding independent
of the linker length (ten, 11 or 12 residues). Additionally, the
conserved residue Arg238 (ARM repeat 4) always binds to the
main chain of all NLS peptides. These residues are conserved
in all Imp proteins from different species (Fontes, Teh, Jans et
al., 2003).
Another important feature of bipartite NLSs (Fontes, Teh,
Jans et al., 2003) and extended monopartite NLSs (Fontes, Teh,
Toth et al., 2003; Cutress et al., 2008; Takeda et al., 2011) is the
region just preceding position P1. In the CN-SV40TAg, Ku70
and human androgen receptor monopartite NLS peptides
additional residues N-terminal to the major-site basic cluster
form favourable interactions with Imp which increase their
affinity for the receptor compared with shorter basic cluster
sequences (Fontes et al., 2000; Takeda et al., 2011; Cutress et al.,
2008; Hu¨bner et al., 1997; Miyamoto et al., 1997). FEN1NLS
Ser364 and Thr365 (two residues preceding the P1 position)
form several hydrogen bonds with Imp. Lys and Asn residues
preceding the P1 position similarly interact with Imp in RB
and N1N2 NLSs. Low values of crystallographic B factors and
the quality of the electron-density maps further suggest that
the C-terminal portion of the linker (closest to the major site)
plays an important role in binding to Imp. Similarly, the
N-terminal portion of the linker (closest to the minor site) also
makes favourable interactions with Imp. Charged and polar
residues in positions P30 and P40 of the FEN1 and N1N2 NLS
peptides interact with Thr322 and Asn280 of Imp, respec-
tively.
Differences in the length of the linker region (defined here
as between positions P20 and P2) in nucleoplasmin and FEN1
(ten residues), RB (11 residues) and N1N2 (12 residues) NLSs
and the presence of specific residues (charged, polar and
proline residues) seem to be the main reasons for the different
conformations of the linkers. The ten-residue linker from
FEN1NLSs has the best-defined electron-density maps and
the largest number of favourable contacts and appears to be
more favourable for Imp binding than longer linkers. In the
N1N2 NLS two linker side-chain residues could not be
modelled owing to a lack of electron density (Fontes, Teh, Jans
et al., 2003). The N1N2 NLS linker requires some short turns
and forces the chain away from Imp, precluding some
favourable interactions. The linker from RB NLS has an
intermediate quality compared with the FEN1 and N1N2
NLSs. In contrast to these results, the ten-residue linker of the
nucleoplasmin NLS structure presents a poorly ordered linker
region, particularly in its central region. This could be a
consequence of the lower resolution of the structure (2.9 A˚)
compared with the other bipartite NLSs and the absence of
acidic and proline residues in the linker region. In summary,
we suggest that shorter linkers appear to be more favourable
because their extended conformations allow the largest
number of favourable contacts with the receptor.
4.3. The relative importance of minor-site and major-site
binding
Mutagenesis studies combined with nuclear localization
assays of FEN1 suggested that this enzyme contains a classical
bipartite NLS. Mutation of 354KRK356 to alanines completely
blocked the localization of the enzyme into the nucleus, while
an analogous experiment for the cluster 365KKK367 led to only
partial blockage of translocation to the nucleus (Qiu et al.,
2001). This result appeared to be paradoxical because binding
of the C-terminal cluster to the major NLS-binding site is
usually considered to make a more significant contribution
energetically (Hodel et al., 2001). This result can now be
explained by the FEN1NLS–Imp structure reported here.
The structure shows that the mutated residues corresponded
to the P1–P3 positions and that the P5 Lys residue remained
intact in the described mutagenesis experiment. The optimal
consensus in the C-terminal major-site-binding basic cluster
has been proposed to be K(K/R)X(K/R) (for positions P2–P5;
Dingwall & Laskey 1991); however, other studies with
different NLS sequences have demonstrated that not all of
these positions must be occupied by Lys or Arg residues. A
number of studies established that Lys in position P2 abol-
ished nuclear import, whereas the mutation of one of the other
basic residues at P1, P3, P4 or P5 had a smaller effect
(Colledge et al., 1986). A structural study with a nonclassical
NLS (phospholipid scramblase 1 NLS) demonstrated that just
two Lys residues at positions P2 and P5 were sufficient for
nuclear translocation of the peptide (Chen et al., 2005) and in
vivo experiments with the same NLS peptide showed that a
Lys at position P2 was dispensable (Chen et al., 2005). In
addition, a recent study involving the structure of phospho-
lipid scramblase 4 NLS showed that this peptide bound
exclusively to the minor binding site (Lott et al., 2011),
suggesting that the minor site does not merely play a
secondary role. Consistent with this suggestion, mutagenesis
of nucleoplasmin (Fontes, Teh, Jans et al., 2003), RB (Rexach
& Blobel, 1995; Fontes, Teh, Jans ,et al., 2003) and N1N2 (Hu &
Jans, 1999; Fontes, Teh, Jans et al., 2003; Fontes, Teh, Toth et al.,
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Figure 4
Quantitative binding assays. The affinity of Imp for FEN1NLS peptide
was determined using a solid-phase binding assay. The measurements
were performed in duplicate in an mImpIBB concentration range of 0–
50 mM. The average absorbance value (OD450 nm) of individual concen-
tration points (mM) was plotted against the log of the concentration of
mImpIBB. The curve was fitted using the one-site binding equation,
yielding a Kd of 42  6.5 nM. This value corresponds to the high-affinity
binding mode (further low-affinity binding modes may be present).
2003) NLSs revealed that the substitution of the P10 and P20
residues by amino acids other than Arg or Lys abolished
nuclear localization. In the light of the available data, our
structure suggests that in the context of FEN1NLS the minor-
site binding is critical and mutation of the residues in positions
P1–P3 in the C-terminal cluster, while retaining the lysine in
the P5 position, cannot completely abolish binding to Imp
and nuclear import.
4.4. The importance of the linker region for NLS binding
The linker region is variable in both length and amino-acid
composition, with this variability probably being relevant to
the specificity of cargo-protein binding to Imp from different
organisms and different Imp isoforms. Highly reactive inhi-
bitors have been designed for both yeast and mammalian
Imp by systematic replacement of each residue in a 12-
residue linker bipartite NLS (Kosugi et al., 2008). The authors
were able to propose two optimized bipartite NLSs which had
a high content of acidic and proline residues in the central
linker region. However, different linker lengths were not tested
in this experiment. Kosugi et al. (2009) recently proposed
six different Imp-specific NLS classes and found specific
patterns in the bipartite NLS linker region which also included
the prevalence of prolines and acidic residues and the lack of
hydrophobic residues. These results are in agreement with the
polar interactions observed in the structures of the FEN1
and N1N2 NLSs (Fig. 5). The presence of polar and charged
residues may be responsible for the fivefold higher affinity for
Imp of N1N2 NLS compared with RB NLS, despite N1N2
having a longer linker that lacks some contacts with Imp
(Fontes, Teh, Jans et al., 2003). FEN1 NLS also has polar and
charged residues adjacent to the basic clusters and in the
central linker region which interact with the receptor, has two
proline residues that provide rigidity and has an optimal ten-
residue linker length. The result of the
combination of these factors is that the
peptide can make favourable interac-
tions all along its length, resulting in a
well ordered structure and excellent-
quality electron density throughout the
peptide compared with other bipartite
NLSs with available structures
(nucleoplasmin, N1N2 and RB). We
propose that the linker region is not
only a region that links the major and
minor binding sites but also contributes
significantly to specificity of transport
receptor binding.
5. Conclusions
We confirmed that the FEN1 NLS
peptide can bind to Imp as a classical
bipartite NLS but using different resi-
dues to those proposed previously. We
also reaffirmed the importance of Imp
residues Arg315, Tyr277 and Arg238 in bipartite NLS binding
and additionally identified polar residues in the NLS linker
region adjacent to the major and minor NLS-binding sites that
contribute to the specificity of bipartite NLS binding. Lys and
Arg residues in positions P10 and P20 may play a more critical
role than some of the basic residues that bind to the major
NLS-binding site in FEN1 NLS and bipartite NLSs in general.
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